USE OF ALLOGENEIC EFFECTOR CELLS AND ANTI-CS1 ANTIBODIES FOR SELECTIVE KILLING OF MULTIPLE MYELOMA CELLS

• 1. 抗CD2抗体药物缀合物(ADC)在同种异体细胞疗法中的用途 [P] . 中国专利： CN112739341A . 2021-04-30
• 2. 抗CD5抗体药物缀合物(ADC)在同种异体细胞疗法中的用途 [P] . 中国专利： CN112739340A . 2021-04-30
• 3. USE OF ALLOGENEIC EFFECTOR CELLS AND ANTI-CS1 ANTIBODIES FOR SELECTIVE KILLING OF MULTIPLE MYELOMA CELLS [P] . 美国专利： US2008095768A1 . 2008-04-24

  机译： 使用同种异体效应细胞和抗CS1抗体选择性杀死多个骨髓瘤细胞

• 4. USE OF ALLOGENEIC EFFECTOR CELLS AND ANTI-CS1 ANTIBODIES FOR SELECTIVE KILLING OF MULTIPLE MYELOMA CELLS [P] . 世界知识产权组织专利： WO2008019379A3 . 2008-04-03

  机译： 使用同种异体效应细胞和抗CS1抗体选择性杀死多个骨髓瘤细胞

• 5. USE OF ALLOGENEIC EFFECTOR CELLS AND ANTI-CS1 ANTIBODIES FOR SELECTIVE KILLING OF MULTIPLE MYELOMA CELLS [P] . 世界知识产权组织专利： WO2008019379A2 . 2008-02-14

  机译： 使用同种异体效应细胞和抗CS1抗体选择性杀死多个骨髓瘤细胞

• 1. Effects of Interleukin 4 on the Phenotype Expression Related to Antibody Production of Peripheral Blood Cells in Patients with Multiple Myeloma [J] . 侯健, 胥军民, 孔宪涛 中国医学科学杂志：英文版 . 1998,第002期
• 2. SELECTIVE KILLING OF GASTRIC CANCER CELLS BY MONOCLONAL ANTIBODY CONJUGATED WITH A CHAIN OF RICIN [J] . 中国癌症研究（英文版） . 1989,第004期
• 3. Effects of Bortezomib and Dexamethasone combination on treating senile multiple myeloma and influence on immune suppressed factors and immune cell levels [J] . Huan Wang, Zhen Zhao, Tao Zhang, 海南医科大学学报（英文版） . 2017,第002期
• 4. Effects of Bortezomib and Dexamethasone combination on treating senile multiple myeloma and influence on immune suppressed factors and immune cell levels [J] . Huan Wang, Zhen Zhao, Tao Zhang, 海南医科大学学报(英文版) . 2017,第002期
• 5. Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu. [J] . Tai YT, Dillon M, Song W, Blood: The Journal of the American Society of Hematology . 2008,第4期
• 6. Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma [J] . Yu-Tzu Tai, Patrick A. Mayes, Chirag Acharya, Blood: The Journal of the American Society of Hematology . 2014,第20期
• 7. Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation. [J] . Bendandi M, Rodriguez Calvillo M, Inoges S, Leukemia and lymphoma . 2006,第1期
• 8. Development of a Fully Human T-Cell Engaging Bispecific Antibody for the Treatment of Multiple Myeloma [C] . Duy T. Pham, Ben Buelow, Priya Choudry, Protein Engineering Summit. . 2018
• 9. The Role of Klf9 in Cell Stress-Induced Cell Death In Normal Cells and in the Therapeutic Response of Multiple Myeloma Cells to Proteasome Inhibitors [D] . Fink, Emily 2017
• 10. Neoplasia: Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu [O] . Yu-Tzu Tai, Myles Dillon, Weihua Song, -1
• 11. Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu [O] . Tai, Yu-Tzu, Dillon, Myles, Song, Weihua, 2008

• 1. Inhibitory Effects of Parthenolide on the Angiogenesis Induced by Human Multiple Myeloma Cells and the Mechanism [J] . Fancong KONG ,Zhichao CHEN ,Qiubai LI . 华中科技大学学报（医学）（英德文版） . 2008,第005期
• 2. 同种异体抗角蛋白自身抗体对家兔接触性皮炎模型IL-6、IL-8的影响 [C] . (Missing) . 2001中国中西医结合皮肤性病学术会议 . 2001
• 3. 移植前选择性去除同种异体反应供者淋巴细胞预防移植物抗宿主病的实验研究 [A] . 董伟民 . 2006